Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension

Yiqiang Zhou, Pengcheng Luo, Hsin Hsin Chang, Hui Huang, Tianxin Yang, Zheng Dong, Cong Yi Wang, Mong-Heng Wang

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Clofibrate, a peroxisome proliferator-activated receptor-α (PPARα) agonist, increases renal tubular cytochrome P450 4a (Cyp4a) expression thereby increasing 20-hydroxyeicosatetraenoic acid (20-HETE) production. To determine if clofibrate affects blood pressure regulation we studied mice with DOCA-salt induced hypertension in wild-type and PPARα knockout mice. Wild-type mice treated with DOCA-salt had higher mean arterial pressures and higher cumulative sodium balance, but lower renal 20-HETE production than did vehicle-treated mice. Treating DOCA-salt mice with clofibrate attenuated the increase in mean arterial pressure and cumulative sodium balance while increasing 20-HETE production and renal Cyp4a expression. In contrast the PPARα knockout mice treated with clofibrate and DOCA-salt showed no attenuation in the increase of blood pressure, cumulative sodium balance, renal 20-HETE production or Cyp4a protein expression. Expression of the PPARα protein was greater in proximal tubules than in renal microvessels. Our results show that PPARα pathway induces renal tubular 20-HETE production which affects sodium retention and blood pressure regulation in DOCA-salt-treated mice.

Original languageEnglish (US)
Pages (from-to)1040-1048
Number of pages9
JournalKidney International
Volume74
Issue number8
DOIs
StatePublished - Oct 1 2008

Fingerprint

Desoxycorticosterone Acetate
Peroxisome Proliferator-Activated Receptors
Clofibrate
Salts
Sodium
Blood Pressure
Hypertension
Kidney
Cytochrome P-450 Enzyme System
Knockout Mice
Arterial Pressure
Proximal Kidney Tubule
Microvessels
Proteins
20-hydroxy-5,8,11,14-eicosatetraenoic acid

Keywords

  • 20-hydroxyeicosatetraenoic acid
  • DOCA
  • Hypertension
  • PPARα

ASJC Scopus subject areas

  • Nephrology

Cite this

Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension. / Zhou, Yiqiang; Luo, Pengcheng; Chang, Hsin Hsin; Huang, Hui; Yang, Tianxin; Dong, Zheng; Wang, Cong Yi; Wang, Mong-Heng.

In: Kidney International, Vol. 74, No. 8, 01.10.2008, p. 1040-1048.

Research output: Contribution to journalArticle

Zhou, Yiqiang ; Luo, Pengcheng ; Chang, Hsin Hsin ; Huang, Hui ; Yang, Tianxin ; Dong, Zheng ; Wang, Cong Yi ; Wang, Mong-Heng. / Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension. In: Kidney International. 2008 ; Vol. 74, No. 8. pp. 1040-1048.
@article{6ed492bc1f7d404685a557c2a87668e4,
title = "Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension",
abstract = "Clofibrate, a peroxisome proliferator-activated receptor-α (PPARα) agonist, increases renal tubular cytochrome P450 4a (Cyp4a) expression thereby increasing 20-hydroxyeicosatetraenoic acid (20-HETE) production. To determine if clofibrate affects blood pressure regulation we studied mice with DOCA-salt induced hypertension in wild-type and PPARα knockout mice. Wild-type mice treated with DOCA-salt had higher mean arterial pressures and higher cumulative sodium balance, but lower renal 20-HETE production than did vehicle-treated mice. Treating DOCA-salt mice with clofibrate attenuated the increase in mean arterial pressure and cumulative sodium balance while increasing 20-HETE production and renal Cyp4a expression. In contrast the PPARα knockout mice treated with clofibrate and DOCA-salt showed no attenuation in the increase of blood pressure, cumulative sodium balance, renal 20-HETE production or Cyp4a protein expression. Expression of the PPARα protein was greater in proximal tubules than in renal microvessels. Our results show that PPARα pathway induces renal tubular 20-HETE production which affects sodium retention and blood pressure regulation in DOCA-salt-treated mice.",
keywords = "20-hydroxyeicosatetraenoic acid, DOCA, Hypertension, PPARα",
author = "Yiqiang Zhou and Pengcheng Luo and Chang, {Hsin Hsin} and Hui Huang and Tianxin Yang and Zheng Dong and Wang, {Cong Yi} and Mong-Heng Wang",
year = "2008",
month = "10",
day = "1",
doi = "10.1038/ki.2008.300",
language = "English (US)",
volume = "74",
pages = "1040--1048",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension

AU - Zhou, Yiqiang

AU - Luo, Pengcheng

AU - Chang, Hsin Hsin

AU - Huang, Hui

AU - Yang, Tianxin

AU - Dong, Zheng

AU - Wang, Cong Yi

AU - Wang, Mong-Heng

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Clofibrate, a peroxisome proliferator-activated receptor-α (PPARα) agonist, increases renal tubular cytochrome P450 4a (Cyp4a) expression thereby increasing 20-hydroxyeicosatetraenoic acid (20-HETE) production. To determine if clofibrate affects blood pressure regulation we studied mice with DOCA-salt induced hypertension in wild-type and PPARα knockout mice. Wild-type mice treated with DOCA-salt had higher mean arterial pressures and higher cumulative sodium balance, but lower renal 20-HETE production than did vehicle-treated mice. Treating DOCA-salt mice with clofibrate attenuated the increase in mean arterial pressure and cumulative sodium balance while increasing 20-HETE production and renal Cyp4a expression. In contrast the PPARα knockout mice treated with clofibrate and DOCA-salt showed no attenuation in the increase of blood pressure, cumulative sodium balance, renal 20-HETE production or Cyp4a protein expression. Expression of the PPARα protein was greater in proximal tubules than in renal microvessels. Our results show that PPARα pathway induces renal tubular 20-HETE production which affects sodium retention and blood pressure regulation in DOCA-salt-treated mice.

AB - Clofibrate, a peroxisome proliferator-activated receptor-α (PPARα) agonist, increases renal tubular cytochrome P450 4a (Cyp4a) expression thereby increasing 20-hydroxyeicosatetraenoic acid (20-HETE) production. To determine if clofibrate affects blood pressure regulation we studied mice with DOCA-salt induced hypertension in wild-type and PPARα knockout mice. Wild-type mice treated with DOCA-salt had higher mean arterial pressures and higher cumulative sodium balance, but lower renal 20-HETE production than did vehicle-treated mice. Treating DOCA-salt mice with clofibrate attenuated the increase in mean arterial pressure and cumulative sodium balance while increasing 20-HETE production and renal Cyp4a expression. In contrast the PPARα knockout mice treated with clofibrate and DOCA-salt showed no attenuation in the increase of blood pressure, cumulative sodium balance, renal 20-HETE production or Cyp4a protein expression. Expression of the PPARα protein was greater in proximal tubules than in renal microvessels. Our results show that PPARα pathway induces renal tubular 20-HETE production which affects sodium retention and blood pressure regulation in DOCA-salt-treated mice.

KW - 20-hydroxyeicosatetraenoic acid

KW - DOCA

KW - Hypertension

KW - PPARα

UR - http://www.scopus.com/inward/record.url?scp=53049090496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53049090496&partnerID=8YFLogxK

U2 - 10.1038/ki.2008.300

DO - 10.1038/ki.2008.300

M3 - Article

C2 - 18596730

AN - SCOPUS:53049090496

VL - 74

SP - 1040

EP - 1048

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 8

ER -